Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia

被引:11
作者
Basile, Umberto [1 ]
Marino, Mariapaola [2 ]
Gragnani, Laura [3 ,4 ]
Napodano, Cecilia [5 ]
Gulli, Francesca [6 ]
Pocino, Krizia [5 ]
Lorini, Serena [3 ,4 ]
Santini, Stefano Angelo [1 ]
Basile, Valerio [7 ]
Miele, Luca [5 ]
Zignego, Anna Linda [3 ,4 ]
Rapaccini, Gian Ludovico [5 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Ist Patol Gen, Rome, Italy
[3] AOUC, Interdept Ctr Syst Manifestn Hepatitis Viruses MA, Dept Expt & Clin Med, Florence, Italy
[4] AOUC, Dept Oncol, Florence, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Med Interna & Gastroenterol, Rome, Italy
[6] Osped Madre Giuseppina Vannini, Dipartimento Med Lab, Rome, Italy
[7] Univ Tor Vergata, Dipartimento Med Lab, Rome, Italy
关键词
Hepatitis C virus; Mixed cryoglobulinemia; Free light chains; Vascular endothelial growth factor; Biomarkers; FREE LIGHT-CHAINS; ENDOTHELIAL GROWTH-FACTOR; VEGF; LYMPHOMA;
D O I
10.1016/j.jim.2019.112687
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Infections, autoimmunity and cancer play a role as determinants of etiology in Hepatitis C virus (HCV) related mixed cryoglobulinemia (MC). Several factors of risk have been suggested as markers of pathogenesis and progression of HCV-related MC into B cell Non-Hodgkin's Lymphoma (B-NHL). Here, we evaluated IgG subclass distribution, free light chains (FLCs) and vascular endothelial growth factor (VEGF) as a new combination of biomarkers. Methods: We measured IgG1-4 subclasses, FLCs and VEGF levels in sera 53 from HCV-related MC, in comparison with 40 sera from HCV negative patients with rheumatoid arthritis (RA) and 30 from healthy blood donors (HBD). Results: IgG3 levels were significantly higher in HCV-MC patients with a decrement of IgG2 and IgG4; FLC levels significantly increased in both MC and RA patients' groups; serological VEGF was higher in HCV-MC patients than in HBD in correlation with k and lambda levels. Conclusion: Our results suggest that a specific IgG subclasses pattern together with raised levels of FLCs and VEGF could represent the biomarker "signature" of an inflammation multistage of acquired immune system.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: Meta-analysis of clinical studies
    Fabrizi, Fabrizio
    Dixit, Vivek
    Messa, Piergiorgio
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (06) : 1019 - 1027
  • [32] Cerebral vasculitis in a patient with HCV-related type II mixed cryoglobulinemia
    Arena, MG
    Ferlazzo, E
    Bonanno, D
    Quattrocchi, P
    Ferlazzo, B
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2003, 13 (02) : 135 - 136
  • [33] Reply: B-cell Frequency in HCV-Related Mixed Cryoglobulinemia
    Holz, Lauren E.
    Yoon, Joo Chun
    Raghuraman, Sukanya
    Moir, Susan
    Sneller, Michael C.
    Rehermann, Barbara
    HEPATOLOGY, 2013, 58 (01) : 448 - 449
  • [34] Recent advances in the treatment of HCV cryoglobulinemia vasculitis
    Cacoub, Patrice
    PRESSE MEDICALE, 2011, 40 (11): : 991 - 994
  • [35] Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia
    Antonelli, Alessandro
    Ferri, Clodoveo
    Ferrari, Silvia Martina
    Colaci, Michele
    Fallahi, Poupak
    AUTOIMMUNITY REVIEWS, 2008, 8 (01) : 18 - 23
  • [36] Mixed cryoglobulinemia
    Clodoveo Ferri
    Orphanet Journal of Rare Diseases, 3
  • [37] Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study
    Gragnani, Laura
    Piluso, Alessia
    Urraro, Teresa
    Fabbrizzi, Alessio
    Fognani, Elisa
    Petraccia, Luisa
    Genovesi, Alessandro
    Giubilei, Lidia
    Ranieri, Jessica
    Stasi, Cristina
    Monti, Monica
    Zignego, Anna Linda
    CURRENT DRUG TARGETS, 2017, 18 (07) : 772 - 785
  • [38] Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: Case report and literature review
    Donato, Maria Francesca
    Banfi, Giovanni
    Cresseri, Donata
    Fogazzi, G. Battista
    Martin, Paul
    Messa, Piergiorgio
    Fabrizi, Fabrizio
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2013, 36 (05) : 367 - 372
  • [39] Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus
    Sene, D
    Ghillani-Dalbin, P
    Thibault, V
    Guis, L
    Musset, L
    Duhaut, P
    Poynard, T
    Piette, JC
    Cacoub, P
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (11) : 2199 - 2206
  • [40] Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients
    Basse, G
    Ribes, D
    Kamar, N
    Mehrenberger, M
    Esposito, L
    Guitard, J
    Lavayssière, L
    Oksman, F
    Dur, D
    Rostaing, L
    TRANSPLANTATION, 2005, 80 (11) : 1560 - 1564